Donald Landry: Difference between revisions
m Reverted edits by BoudiccaB (talk) to last revision by Ira Leviton: addition of unsourced content to a biographical article |
I am Dr. Landry's Chief of Staff. SOmeone (not him)created a wikipedia page about him, and it was incorrect. He has written this himself, and both he and i can verify any information you may need. Tags: possible unreferenced addition to BLP references removed |
||
| Line 1: | Line 1: | ||
Donald W. Landry, M.D., Ph.D., the Hamilton Southworth Professor of Medicine, is Chair of the Department of Medicine at Columbia University and Physician-in-Chief at NewYork-Presbyterian Hospital/Columbia University Medical Center since 2008. He is also past founding director of the Division of Experimental Therapeutics, and past director of the Division of Nephrology. Dr. Landry completed his Ph.D. in Organic Chemistry with Nobel laureate R.B. Woodward at Harvard University in 1979 and then obtained the M.D. degree from Columbia University in 1983. After completing his Residency in Internal Medicine at the Massachusetts General Hospital/Harvard Medical School, he returned to Columbia for training as an NIH Physician-Scientist, 1985-90, and has remained as a member of the Columbia faculty. |
|||
'''Donald Landry''' is a [[physician]], [[Organic chemistry|organic chemist]], and [[Nephrology|nephrologist]] known for his contributions to [[Cardiovascular disease|cardiovascular biology]] and [[Oncology|cancer research]]. Landry’s scientific and medical innovations have been recognized through various awards, including the [[Presidential Citizens Medal]] in 2009<ref>{{Cite web|url=https://www.nyp.org/news/Dr-Donald-Landry-Honored-With-Presidential-Citizens-Medal|title=Dr. Donald Landry Honored With Presidential Citizens Medal - NewYork-Presbyterian|website=www.nyp.org|language=en|access-date=2020-01-15}}</ref> and his induction into the [[New Jersey Inventors Hall of Fame]] in 2016.<ref>{{Cite web|url=http://www.njinvent.org/2016-awardees.html|title=2016 Awardees|website=NJ Inventors Hall of Fame 2018|language=en|access-date=2020-01-15}}</ref> |
|||
Dr. Landry has focused on novel approaches to intractable health problems, combining medicine and organic chemistry. His work on cocaine addiction led to the discovery of an artificial enzyme to degrade cocaine. His report on the enzyme, published in Science, was chosen by the American Chemical Society as one of the 25 most important chemistry papers in the world for 1993. An agent he co-developed to treat cocaine overdose has entered clinical trials. He founded the Columbia Organic Chemistry Collaborative Center and it is through this Center that he conducts his current work on drug discovery. |
|||
Landry is credited for the creation of an alternative method for [[stem cell]] extraction - using dead embryos rather than live ones - which became central to the [[Presidency of George W. Bush|George W. Bush Administration]]’s policy decisions on the topic.<ref>{{Cite news|url=https://www.wsj.com/articles/SB118195806468937442|title=The Devout Doctor's Prescription|last=Naik|first=Gautam|date=2007-06-16|work=Wall Street Journal|access-date=2020-01-15|language=en-US|issn=0099-9660}}</ref> He is also known for identifying a vasopressin deficiency in vasodilatory shock, leading to the current clinical use of [[vasopressin]] to treat septic shock and [[vasodilatory shock]]. Additionally, he has created a variety of other advancements in medical treatment, introducing [[renal replacement therapy]] to treat [[kidney failure]], and anti-cocaine antibodies. |
|||
Dr. Landry discovered a new hormone deficiency syndrome: vasopressin deficiency in vasodilatory shock. In pioneering the use of vasopressin to treat septic shock and vasodilatory shock after cardiopulmonary bypass, he changed clinical practice for these life-threatening conditions. He also founded ICU nephrology at Columbia, introducing continuous renal replacement therapy to treat renal failure in patients with shock. |
|||
Dr. Landry is a member of the [[American Chemical Society]], the [[New York Academy of Sciences]], the [[American Society for Clinical Investigation]], the [[Association of American Physicians]], the Practitioners Society of New York, and the [[American Society for Pharmacology and Experimental Therapeutics]]. He has published more than 160 articles in peer-reviewed journals, and holds over 20 patents.<ref>{{Cite web|url=https://patents.justia.com/inventor/donald-landry|title=Donald Landry Inventions, Patents and Patent Applications - Justia Patents Search|website=patents.justia.com|access-date=2020-01-15}}</ref> He is currently the chairman Department of Medicine at the Columbia University College of Physicians and Surgeons (P&S).<ref name=":0">{{Cite web|url=https://www.cuimc.columbia.edu/news/donald-landry-named-p-s-chair-medicine|title=Donald Landry Named P&S Chair Of Medicine|date=2008-11-05|website=Columbia University Irving Medical Center|language=en|access-date=2020-01-15}}</ref> |
|||
Dr. Landry developed an alternative method for the production of human embryonic stem cells that relies on harvesting live, normal cells from embryos that-- by objective, peer-reviewed criteria-- have died of natural causes. Cells harvested from dead embryos would be covered under the established ethics governing transplantation of essential organs from deceased donors. |
|||
Dr. Landry directed the Doris Duke Clinical Research Fellowship Program's Columbia site and co-directed the Advanced Pathophysiology course for 4th-year medical students at the Columbia College of Physicians and Surgeons, both for over a decade. Dr. Landry was a member of the President's Council on Bioethics and is co-chair of the Witherspoon Council for Ethics and the Integrity of Science. He is a founder of Tonix Pharmaceuticals, a member of the Board of Directors of Sensient Technologies, and chair of the scientific advisory board of Applied Therapeutics, Inc., which was founded based on his patents and now trades on NASDAQ. He is co-founder of Tegrigen Therapeutics, a biotech start-up focused on integrin targets. |
|||
Dr. Landry was elected to membership of the American Society for Clinical Investigation and the Association of American Physicians. He is listed in Who's Who in the World and in 2015 was inducted at the Smithsonian as an elected Fellow of the National Academy of Inventors. Dr. Landry received the Presidential Citizens Medal, the nation's second-highest civilian honor, from President George W. Bush at the Oval Office in 2008 "for diverse and pioneering research and his efforts to improve the well-being of his fellow man." |
|||
His wife, Maureen, graduated from Harvard College summa cum laude and is a Ph.D. clinical psychologist and psychoanalyst in the Department of Psychiatry, Columbia University. His elder son majored in Classics and Russian Studies at Yale, received the MD degree from Columbia University Vagelos College of Physicians and Surgeons and is in Residency in Psychiatry at NewYork-Presbyterian/Columbia; his younger son concentrated in Physics and Math at Harvard; completed a PhD in theoretical physics at Columbia and is a postdoctoral fellow in theoretical physics at Massachusetts Institute of Technology. He resides in Manhattan where he is a member of the Central Park Track Club. |
|||
== Education == |
|||
Landry received his B.S. from [[Lafayette College]], received his medical degree from [[Columbia University College of Physicians and Surgeons]], and received his doctorate in organic chemistry from [[Harvard University]]. He completed residency in internal medicine at Massachusetts General Hospital and [[Harvard Medical School]]. He then trained in [[nephrology]] as an [[National Institutes of Health|NIH]] Physician-Scientist.<ref name=":0" /> |
|||
== References == |
== References == |
||
Revision as of 18:33, 9 March 2022
Donald W. Landry, M.D., Ph.D., the Hamilton Southworth Professor of Medicine, is Chair of the Department of Medicine at Columbia University and Physician-in-Chief at NewYork-Presbyterian Hospital/Columbia University Medical Center since 2008. He is also past founding director of the Division of Experimental Therapeutics, and past director of the Division of Nephrology. Dr. Landry completed his Ph.D. in Organic Chemistry with Nobel laureate R.B. Woodward at Harvard University in 1979 and then obtained the M.D. degree from Columbia University in 1983. After completing his Residency in Internal Medicine at the Massachusetts General Hospital/Harvard Medical School, he returned to Columbia for training as an NIH Physician-Scientist, 1985-90, and has remained as a member of the Columbia faculty.
Dr. Landry has focused on novel approaches to intractable health problems, combining medicine and organic chemistry. His work on cocaine addiction led to the discovery of an artificial enzyme to degrade cocaine. His report on the enzyme, published in Science, was chosen by the American Chemical Society as one of the 25 most important chemistry papers in the world for 1993. An agent he co-developed to treat cocaine overdose has entered clinical trials. He founded the Columbia Organic Chemistry Collaborative Center and it is through this Center that he conducts his current work on drug discovery.
Dr. Landry discovered a new hormone deficiency syndrome: vasopressin deficiency in vasodilatory shock. In pioneering the use of vasopressin to treat septic shock and vasodilatory shock after cardiopulmonary bypass, he changed clinical practice for these life-threatening conditions. He also founded ICU nephrology at Columbia, introducing continuous renal replacement therapy to treat renal failure in patients with shock.
Dr. Landry developed an alternative method for the production of human embryonic stem cells that relies on harvesting live, normal cells from embryos that-- by objective, peer-reviewed criteria-- have died of natural causes. Cells harvested from dead embryos would be covered under the established ethics governing transplantation of essential organs from deceased donors.
Dr. Landry directed the Doris Duke Clinical Research Fellowship Program's Columbia site and co-directed the Advanced Pathophysiology course for 4th-year medical students at the Columbia College of Physicians and Surgeons, both for over a decade. Dr. Landry was a member of the President's Council on Bioethics and is co-chair of the Witherspoon Council for Ethics and the Integrity of Science. He is a founder of Tonix Pharmaceuticals, a member of the Board of Directors of Sensient Technologies, and chair of the scientific advisory board of Applied Therapeutics, Inc., which was founded based on his patents and now trades on NASDAQ. He is co-founder of Tegrigen Therapeutics, a biotech start-up focused on integrin targets.
Dr. Landry was elected to membership of the American Society for Clinical Investigation and the Association of American Physicians. He is listed in Who's Who in the World and in 2015 was inducted at the Smithsonian as an elected Fellow of the National Academy of Inventors. Dr. Landry received the Presidential Citizens Medal, the nation's second-highest civilian honor, from President George W. Bush at the Oval Office in 2008 "for diverse and pioneering research and his efforts to improve the well-being of his fellow man."
His wife, Maureen, graduated from Harvard College summa cum laude and is a Ph.D. clinical psychologist and psychoanalyst in the Department of Psychiatry, Columbia University. His elder son majored in Classics and Russian Studies at Yale, received the MD degree from Columbia University Vagelos College of Physicians and Surgeons and is in Residency in Psychiatry at NewYork-Presbyterian/Columbia; his younger son concentrated in Physics and Math at Harvard; completed a PhD in theoretical physics at Columbia and is a postdoctoral fellow in theoretical physics at Massachusetts Institute of Technology. He resides in Manhattan where he is a member of the Central Park Track Club.
References
 | This article needs additional or more specific categories. (January 2020) |